SCHEMBL14419776

SCHEMBL14419776

N=C(CCl)NC(=O)c1ccc(-c2cccs2)s1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.64
▸ ALDH1A1 P00352 4/20 0.54
▸ KDM4E B2RXH2 4/20 0.54
▸ LMNA P02545 3/20 0.54
▸ GAA P10253 2/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ GLA P06280 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ NPC1 O15118 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ HPGD P15428 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ TP53 P04637 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ CASP1 P29466 1/20 0.52
▸ CASP7 P55210 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8572921 0.79 ALDH1A1 (0.63) HDAC1ALDH1A1KDM4ELMNAGAA
SCHEMBL8328245 0.79 HDAC1 (0.76) HDAC1ALDH1A1KDM4ELMNAGAA
SCHEMBL5903723 0.79 HDAC1 (1.00) HDAC1ALDH1A1KDM4ELMNAGAA
SCHEMBL8571740 0.78 ALDH1A1 (0.61) HDAC1ALDH1A1KDM4ELMNAGAA
SCHEMBL13857534 0.75 HDAC1 (0.73) HDAC1ALDH1A1KDM4ELMNAGAA
SCHEMBL13930616 0.74 HDAC1 (0.58) HDAC1ALDH1A1KDM4ELMNAGAA
SCHEMBL3054745 0.74 ALDH1A1 (0.69) HDAC1ALDH1A1KDM4ELMNAGAA
SCHEMBL7870469 0.73 ALDH1A1 (0.89) HDAC1ALDH1A1KDM4ELMNAGAA
Potassium Ion SCHEMBL25278002 0.72 ALDH1A1 (0.67) HDAC1ALDH1A1KDM4ELMNAGAA
SCHEMBL15803999 0.72 ALDH1A1 (0.67) HDAC1ALDH1A1KDM4ELMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268115-B2 Cyclic peptides; three-dimensional structures; screening; anticancer agents; angiogenesis inhibitors; drug delivery ADHEREX TECHNOLOGIES, INC. (CA) 2007-09-11 — — US disclosed
Send feedback